Marketing

  • Side view portrait of doctor and patient talking in a clinic setting.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Deep Dive

    AI could transform healthcare. Can safety-net providers keep up?

    Implementing artificial intelligence requires significant human labor and technical expertise, threatening to create a digital divide between highly resourced health systems and safety-net providers.

    By Emily Olsen • Oct. 3, 2025
  • The exterior of Amgen's office building in South San Francisco, with a sculpted company sign in the foreground and leafless trees on a grassy lawn.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Amgen claims ‘landmark’ study result that could widen heart drug’s use

    In a first-of-its-kind finding, Amgen’s PCSK9 drug protected heart health when tested as a “primary prevention” therapy, which could pave the way for access to a much broader population. 

    By • Oct. 2, 2025
  • A stylized illustration of a pill breaking apart into smaller pills. Explore the Trendline➔
    Image attribution tooltip
    Brian Tucker / BioPharma Dive/BioPharma Dive
    Image attribution tooltip
    Trendline

    Commercialization

    New drugs for obesity and Alzheimer’s look set to become blockbusters, reshaping pharma marketing strategies just as many current top-sellers near looming patent cliffs.

    By BioPharma Dive staff
  • U.S. President Donald Trump shakes hands with President of the European Commission Ursula von der Leyen as he announces a trade deal with the EU at Trump Turnberry golf club on July 27, 2025 .
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Pharma reshoring

    Key exemptions could limit impact of Trump’s pharmaceutical tariffs

    Carve-outs for generics, European exports and companies onshoring drug production will likely shield most branded drugs from the 100% levies Trump announced Thursday.

    By • Sept. 26, 2025
  • A child receives a standard immunization at Dr. Gary Kramer's pediatric office on September 15, 2025, in Coral Gables, Florida.
    Image attribution tooltip
    Joe Raedle / Staff via Getty Images
    Image attribution tooltip
    Deep Dive

    Disparity in vaccine access between states roils patients, providers

    Recent changes to federal guidance on COVID vaccinations have providers worried about what’s to come. “We have opened a door to not using science to guide care,” one physician said.

    By Susanna Vogel • Sept. 23, 2025
  • A person in business attire points while seated at a conference table with other people.
    Image attribution tooltip
    Elijah Nouvelage via Getty Images
    Image attribution tooltip
    Vaccines

    CDC panel, recast by RFK Jr., softens COVID vaccine recommendations

    After a tumultuous two-day meeting marked by confusion and missteps, an advisory committee endorsed guidelines that would urge people to discuss vaccination's benefits and risks with their physician.

    By , • Sept. 19, 2025
  • People in business attire speak while seated at a conference table.
    Image attribution tooltip
    Elijah Nouvelage via Getty Images
    Image attribution tooltip
    Vaccines

    CDC advisers postpone vote to delay some newborns’ hepatitis B shot

    Members of ACIP voted to table a planned vote on withholding some infants’ first hepatitis B vaccine dose, adding more confusion to an already muddied meeting.

    By • Sept. 19, 2025
  • A person in business attire speaks into a microphone while seated at a desk.
    Image attribution tooltip
    Kevin Dietsch via Getty Images
    Image attribution tooltip
    Vaccines

    Fired CDC director says RFK Jr. aims to change childhood vaccine schedule

    Susan Monarez told Senators at a hearing Wednesday that Robert F. Kennedy Jr. pushed her out for refusing to rubber-stamp changes.

    By • Sept. 17, 2025
  • People in business attire sit around a conference table.
    Image attribution tooltip
    Elijah Nouvelage / Stringer via Getty Images
    Image attribution tooltip
    Vaccines

    A key CDC panel meets today to discuss vaccines. Here’s what to know.

    The remade ACIP panel is set to vote today on recommendations for use of vaccines for measles and hepatitis B. They’ll meet again tomorrow to discuss COVID shots.

    By • Updated Sept. 15, 2025
  • Image of Johnson & Johnson's Inlexzo, a chemotherapy-eluted implant for treatment of bladder cancer.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    FDA clears J&J’s drug-device combo for bladder cancer

    J&J executives have said they expect the therapy, Inlexzo, to become a future blockbuster and generate sales that significantly outstrip Wall Street forecasts.

    By • Sept. 10, 2025
  • A person in a blue sit sits behind a desk at a hearing.
    Image attribution tooltip
    Andrew Harnik via Getty Images
    Image attribution tooltip
    Trump administration

    At Senate hearing, lawmakers express dissatisfaction with RFK Jr.’s vaccine moves

    Robert F. Kennedy Jr. faced criticism Thursday even from Republicans over changes to federal vaccine policy as well as a leadership crisis at the CDC.

    By , • Sept. 4, 2025
  • Image of a brain in purple outline with red details.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Biohaven’s rare disease drug is ‘ready to ship on Day 1’ following FDA approval

    CEO Vlad Coric said the company has a patient hub, payer managers and a small sales force set up to ensure a successful launch of Vyglxia, a brain medicine that could be approved this year.

    By • Updated Sept. 4, 2025
  • The exterior of Ionis Pharmaceuticals' headquarters in Carlsbad, California.
    Image attribution tooltip
    Courtesy of Ionis Pharmaceuticals
    Image attribution tooltip

    Ionis looks to expand use of lipid-lowering drug after trial hits goal

    Tryngolza, the first wholly owned drug Ionis has launched, helped people with high triglyceride levels that aren’t genetically driven.

    By • Sept. 2, 2025
  • A sign bearing the logo for the Centers for Disease Control and Prevention stands outside of an office building.
    Image attribution tooltip
    Elijah Nouvelage via Getty Images
    Image attribution tooltip
    Vaccines

    CDC panel to discuss COVID, hepatitis B shots in meeting next month

    A federal register notice confirmed dates for the anticipated advisory meeting, which will follow an FDA decision to narrow COVID boosters' approval and comes as CDC leadership is in turmoil.

    By • Aug. 28, 2025
  • Robert F. Kennedy Jr. in a blue stripe suit points while speaking
    Image attribution tooltip
    Andrew Harnik via Getty Images
    Image attribution tooltip

    MAHA may take aim at pharma DTC ads

    RFK Jr. has his sights set on increasing oversight and enforcement against drugmakers that run afoul of advertising laws.

    By Amy Baxter • Aug. 20, 2025
  • Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. testifies before the House Energy and Commerce Committee Health Subcommittee in the Rayburn House Office Building on June 24, 2025 in Washington, DC.
    Image attribution tooltip
    Kayla Bartkowski / Staff via Getty Images
    Image attribution tooltip
    Vaccines

    HHS revives defunct task force on childhood vaccine safety

    The panel’s reinstatement is one of a series of controversial moves made by Robert F. Kennedy Jr. to put vaccines under new scrutiny.

    By • Aug. 15, 2025
  • A photo of CureVac headquarters in Tuebingen, Germany
    Image attribution tooltip
    Courtesy of CureVac AG
    Image attribution tooltip
    Vaccines

    BioNTech ends patent fight with mRNA rival CureVac ahead of buyout deal

    The complex settlement, which hands payouts and royalties to CureVac and partner GSK, comes as BioNTech is inching toward an acquisition of its one-time COVID-19 vaccine competitor.

    By • Aug. 8, 2025
  • Close-up view of the Novo Nordisk logo mounted on the exterior wall of a building. The logo features a stylized blue Apis bull with a sun disk above its head, symbolizing the company's identity. The background shows a tan brick wall and part of a leafless tree in the foreground under a clear blue sky."
    Image attribution tooltip
    Alamy
    Image attribution tooltip
    Obesity drugs

    Novo pushes back against obesity drug compounders as competition intensifies

    The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its slipping position in the lucrative market for weight loss drugs.

    By • Aug. 6, 2025
  • A sign bearing the logo for the Centers for Disease Control and Prevention stands outside of an office building.
    Image attribution tooltip
    Elijah Nouvelage via Getty Images
    Image attribution tooltip
    Vaccines

    Experts ousted from CDC panel warn of damage to US vaccine policy

    The 17 advisers fired in June by Robert F. Kennedy Jr. urged alternatives to ACIP be organized to limit further degradation in vaccine guidelines.

    By • July 31, 2025
  • An Alnylam logo is displayed on a building in Cambridge, Massachusetts, on Sept. 5, 2024.
    Image attribution tooltip
    Jacob Bell/BioPharma Dive
    Image attribution tooltip

    Alnylam reaches new highs on strong sales of closely watched rare disease drug

    Despite battling drugs from BridgeBio and Pfizer, Amvuttra beat Wall Street expectations with results Alnylam’s CEO claimed were “not a flash in the pan.”

    By • July 31, 2025
  • A person seated in an armchair looks up at another in this still image taken from a video commercial.
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip

    J&J tests direct CAR-T marketing with first Carvykti ad

    The new direct-to-consumer ad signals J&J’s confidence in its capacity to meet demand for the cell therapy after earlier manufacturing struggles.

    By • Updated July 30, 2025
  • Kisunla, Eli Lilly
    Image attribution tooltip
    Permission granted by Eli Lilly
    Image attribution tooltip
    Brain drug revival

    In reversal, European regulators take positive view on Lilly Alzheimer’s drug

    Lilly’s appeal of an earlier, negative recommendation from a key EMA committee has worked out in its favor, and puts the drug, Kisunla, one step closer to European market entry.

    By • July 25, 2025
  • U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. testifies before the Senate Committee on Health, Education, Labor, and Pensions on Capitol Hill on May 14, 2025 in Washington, DC.
    Image attribution tooltip
    Anna Moneymaker / Staff via Getty Images
    Image attribution tooltip
    Vaccines

    RFK Jr. adopts CDC panel recommendation to remove thimerosal from flu shots

    The action will remove from use the very few flu shots that contain the contested preservative, elevating unproven fears it poses health risks.

    By • July 23, 2025
  • A photo of Bristol Myers Squibb and Pfizer's anticoagulant drug Eliquis
    Image attribution tooltip
    Scott Olson / Staff via Getty Images
    Image attribution tooltip

    Bristol Myers, Pfizer to offer Eliquis at a discount for some patients

    The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who aren’t insured or are willing to pay cash for their medications. 

    By • July 17, 2025
  • Bottles and cartons of prescription medicines are arranged on shelves.
    Image attribution tooltip
    Spencer Platt via Getty Images
    Image attribution tooltip

    Soleno sales of new Prader-Willi drug rise faster than expected

    Preliminary quarterly sales figures for Vykat surpassed Wall Street estimates, but shares fell on concerns the company may not be courting a buyer.

    By • July 10, 2025
  • A 3D illustration showing amyloid plaques in brain tissue
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Lilly gets FDA OK of modified dosing for Alzheimer’s drug

    A slower ramp-up of Kisunla dosing lowers the rate of dangerous brain swelling, a risk that has made doctors reluctant to prescribe Lilly’s amyloid-busting drug.

    By • July 9, 2025